Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: 8K filed - Rule 24b-2 under the Securities Exchange Act of 1934
7
Jul 17, 2012 04:33PM
1
Jul 17, 2012 04:49PM
1
Jul 17, 2012 04:50PM

Jul 17, 2012 05:49PM
6
Jul 17, 2012 06:53PM

Rule 24b-2 under the Securities Exchange Act of 1934

http://www.qsllp.com/InsightIdeas/ArticleDetails/tabid/85/ArticleId/9/-strong-Keeping-it-Off-the-Record-An-Overview-of-Confidential-Treatment-Requests-strong.aspx

A request for confidential treatment made pursuant to Rule 406 of the Securities Act or Rule 24b-2 of the Exchange Act must:

be sufficiently narrow, so as to only include information eligible for exemption under the FOIA;

specify the basis for the exemption (there are nine FOIA exemptions available, with "trade secrets and commercial or financial information obtained from a person and privileged or confidential" being the most invoked);

contain legal and factual analyses substantiating the exemption;

contain an affirmative representation as to the confidentiality of the information; and

indicate the duration for which the exemption is being sought.

The Commission will not generally grant a request for confidential treatment with respect to information that is specifically required to be disclosed under applicable securities laws or information that is otherwise material to investors.

4
Jul 17, 2012 07:56PM

Jul 17, 2012 08:47PM
2
Jul 17, 2012 11:32PM

Jul 18, 2012 02:03AM
Share
New Message
Please login to post a reply